Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Udenafil demonstrates efficacy in erectile dysfunction phase IIb study

April 3, 2007

Hollis-Eden files IND to begin clinical testing of HE-3286 for metabolic disorders

April 3, 2007

Kyorin's PAA-3352 shows antidiabetic activity in vivo

April 2, 2007

AS-1552133 shows improved preclinical cholesterol- and triglyceride-lowering activity

April 2, 2007

Parathyroid hormone (1-84) reduces vertebral fracture risk in postmenopausal women

April 2, 2007

Eltrombopag increases platelet counts in idiopathic thrombocytopenic purpura

March 29, 2007

Weekly PC-DAC:Exendin-4 lowers blood glucose in type 2 diabetes

March 29, 2007

Recent Banyu and Lilly patents disclose novel antiobesity agents

March 29, 2007

Interim data suggest Nebido trial will meet endpoints

March 29, 2007

Recent patents describe new treatment options for diabetes

March 29, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...